Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients

AstraZeneca3,000 enrolled

Overview

An observational, non-interventional, multi-centre study to provide further information on the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.

Study Type

OBSERVATIONAL

Enrollment

3,000

Conditions

Dyslipidemias

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia * Subjects who have at least made 1 visit to the outpatient clinic within previous 6 months * Subjects who have records of both LDL-C and HDL-C before \& after statin treatment (at least four weeks after statin taking) Exclusion Criteria: * Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Outcomes

Primary Outcomes

Evaluate current LDL/HDL ratio in Korean patients (between baseline & after treatment)

Time frame: After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.

Secondary Outcomes

Evaluate difference of LDL/HDL ratio among different statins & dosages (between baseline & after treatment)

Time frame: After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.